DFX Intelligence
Family Office Intelligence
A continuously maintained graph of U.S. family offices: identity, team, observed investments, public holdings, relationships and dated signals of change. Facts, inferences and estimates are labelled as such, with the source and the date, on every row. Unknown is printed as unknown.
Family office profile
72 Investment Holdings, LLC
72 Cummings Point Road, Stamford, CT 06902 (Point72 campus)Family investment companyidentity confidence 90%Top 500 by research priority
Why this class: Steven A. Cohen's personal holding company at the Point72 address, of which he is the sole member..
Verified Sep 13, 2026 (5 days ago)
Last observed Sep 14, 2026 · 63 observations · 4 sources
3 people · 9 investments · 5 public positions · 14 events
Identity
90
high
Data depth
80
high
Freshness
100
high
Active deployment
0
low
Direct investing
70
high
External managers
0
low
Private markets
60
high
Sponsor-friendly
0
low
Real estate
0
low
Co-investment
10
low
Contactability
20
moderate
Mandate confidence
90
high
Twelve separate dimensions, each 0 to 100 from listed components. There is no single family office score; the components are in the evidence section.
Overview
Profile completeness 66% (high value, high value deep; the most valuable missing fact is contacts)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
- Classification
- Family investment company
- Description
- Under common control with Point72 Asset Management, CPV Partners (Cohen Private Ventures) and Point72 Private Investments, each of which files its own 13F
- Headquarters
- 72 Cummings Point Road, Stamford, CT 06902 (Point72 campus)
- Office address
- unknown
- Business phone
- unknown
- Website
- unknown
- Year established
- unknown
- Assets under management
- unknown
- Foundation assets (IRS)
- $29.0M across 2 related private foundations, per the IRS master file; the foundation's assets, not the office'sFact
- Capital scale
- Reported office AUM: unknown. 13F disclosed value $49.6M. Related foundation assets $29.0M. These are different facts and are never added together.
- Form 13F
- $49.6M across 5 positions, quarter ended Mar 31, 2026. Long 13(f) securities only; never the whole portfolio.Fact
Classification history
- Sep 13, 2026Family investment company 90%Steven A. Cohen's personal holding company at the Point72 address, of which he is the sole member.Factverifiedsec.gov“Steven A. Cohen (SC), the sole member of 72 IH, deemed to have sole voting and investment control over such interest held by 72 IH.”
- Sep 12, 2026Candidate 30%13F filer that is on no adviser roster and is not institutional by name: could be an SFO, a corporate treasury or a trust companyInference
Family and wealth origin
- Family served
- Steven A. Cohen (married to Alexandra Garcia since 1992)
- Source of wealth
- Hedge fund management: S.A.C. Capital Advisors (1992 to 2016) and Point72 Asset Management
- Operating company origin
- unknown
Team
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| Steven a Cohen family | Sole member | Family principal · investment decisions | none on record | sec.gov Fact |
| Jason M. Colombo | Authorized Person | Operations and finance · investment decisions | phone: 203-890-2000 (published by the subject) | sec.gov Fact |
| Jason M. Colombo | Authorized Person | Other | phone: 203-890-2000 (published by the subject) | sec.gov Fact |
Former
Vincent Tortorella, Authorized Signatory, until Sep 13, 2026
Office contact points
Investment mandate
inferred only: public equity book 49601478.0
Stated (their words, cited)
No cited statement of mandate on the record.
Observed (from the investment record)
No investments on the record yet, so nothing is observed.
Inferred (regulatory shape and team)
- Public equity book
- $49.6M Inference13F table value, quarter ended 2026-03-31; long 13(f) securities only
- Invests directly
- Yes; pre-IPO and crossover biotech stakes through Point72 Biotech Private Investments
- Allocates to managers
- unknown
- Asset classes
- unknown
- Sectors
- Biotechnology (immunology, gene editing, neuroscience, ophthalmology, RNA editing, oncology)
- Geography
- unknown
- Check size
- unknown
Direct investments
| Date | Company | Kind | Sector | Role | Amount | With | Source |
|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | LENZ Therapeutics, Inc. | Round participation | Biotech (ophthalmology, presbyopia) | unknown · minority | unknown | none named | sec.gov Fact “NAME OF REPORTING PERSON Point72 Biotech Private Investments, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE O” |
| Feb 6, 2024 | Alto Neuroscience, Inc. | Round participation | Biotech (precision psychiatry) | unknown · minority | unknown | none named | sec.gov Fact “NAME OF REPORTING PERSON Point72 Biotech Private Investments, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE O” |
| Nov 8, 2023 | Korro Bio, Inc. | Round participation | Biotech (RNA editing) | unknown · minority | unknown | none named | sec.gov Fact “NAME OF REPORTING PERSON Point72 Biotech Private Investments, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE O” |
| Jul 26, 2023 | Turnstone Biologics Corp. | Round participation | Biotech (immuno-oncology) | unknown · minority | unknown | none named | sec.gov Fact “NAME OF REPORTING PERSON Point72 Biotech Private Investments, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x 3 SEC USE O” |
| Mar 16, 2021 | Prometheus Biosciences, Inc. (IPO allocation) | Growth | Biotech | participant · minority | $15.2M | none named | sec.gov Fact “Common Stock 03/16/2021 P 800,000 A $ 19 2,648,024 I See Footnote (4)” |
| Mar 11, 2021 | Prometheus Biosciences, Inc. | Round participation | Biotech (immunology, precision medicine) | unknown · minority | unknown | none named | sec.gov Fact “Shares of Series D-1 Preferred Stock are convertible at any time, at the holder's election, at a ratio of ten-for-one share of the Issuer's ” |
| n/a | Caribou Biosciences, Inc. | Round participation | Biotech (CRISPR gene editing) | unknown · minority | unknown | none named | sec.gov Fact “INVESTOR: Point72 Biotech Private Investments, LLC By: /s/ Vincent Tortorella Name: Vincent Tortorella Title: Authorized Signatory” |
| n/a | Praxis Precision Medicines, Inc. | Round participation | Biotech (neuroscience) | unknown · minority | unknown | none named | sec.gov Fact “Purdue Neuroscience Company, Point72 Biotech, OCV, Citadel Multi-Strategy Equities Master Fund Ltd. (“ Surveyor ”), Al-Rayyan and Eventide a” |
Fund and manager relationships
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdings
Stakes the office filed (Schedule 13D, 13G, Section 16)
From EDGAR's index of the office's own filings. A 13D is a stake of 5% or more held with intent, a 13G one held passively, a Form 3, 4 or 5 the office as an insider of the issuer. The size of the stake is inside each filing and is not shown here.
| First filed | Issuer | Filed as | Filings |
|---|---|---|---|
| Mar 11, 2021 | Prometheus Biosciences, Inc. | Section 16 insider | 1x 3, 1x 4 on Prometheus Biosciences, Inc. between 2021-03-11 and 2021-03-17 sec.gov |
Form 13F holdings
Top 5 positions of 5 for the quarter ended Mar 31, 2026; $49.6M shown of $49.6M reported. Long 13(f) securities only. Never presented as the whole portfolio.
| Issuer | Class | Value | Shares | Weight |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | COM NEW | $21.2M | 65,933 | 42.8% |
| ALTO NEUROSCIENCE INC | COM SHS | $15.0M | 667,778 | 30.3% |
| LENZ THERAPEUTICS INC | COM | $9.3M | 1,017,751 | 18.8% |
| KORRO BIO INC | COM | $3.1M | 276,831 | 6.3% |
| CARIBOU BIOSCIENCES INC | COM | $900,727 | 474,067 | 1.8% |
Real estate
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors
No co-investor on the record.
Independent sponsor relationships
No cited relationship to an independent sponsor.
Signals and timeline
Most significant first: what kind of change it is, its size, whose change it is, and how recent. 8 events. 13F position changes are under Public stakes and holdings.
- Sep 13, 2026Classification changed72 Investment Holdings, LLC: CANDIDATE_FAMILY_OFFICE -> FAMILY_INVESTMENT_COMPANY (Steven A. Cohen's personal holding company at the Point72 address, of which he is the sole member.)ClassificationFactsec.gov
- Sep 11, 2026Office discovered72 Investment Holdings, LLC files Form 13F (non_adviser_filer, $50,574,739 in 5 positions)DiscoveryInferencesec.gov
- Mar 22, 2024Direct investment72 Investment Holdings, LLC invested in LENZ Therapeutics, Inc.Direct investmentsFactsec.gov
- Feb 6, 2024Direct investment72 Investment Holdings, LLC invested in Alto Neuroscience, Inc.Direct investmentsFactsec.gov
- Nov 8, 2023Direct investment72 Investment Holdings, LLC invested in Korro Bio, Inc.Direct investmentsFactsec.gov
- Jul 26, 2023Direct investment72 Investment Holdings, LLC invested in Turnstone Biologics Corp.Direct investmentsFactsec.gov
- Mar 16, 2021Direct investment72 Investment Holdings, LLC invested in Prometheus Biosciences, Inc. (IPO allocation)Direct investmentsFactsec.gov
- Mar 11, 2021Direct investment72 Investment Holdings, LLC invested in Prometheus Biosciences, Inc.Direct investmentsFactsec.gov
Sources and evidence
Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 64 shown.
Score components
Freshness
+100 days since the newest source-dated fact or analyst verification (4 days)
Contactability
+20 verified business phones (2)
Data confidence
+10 description
+10 stated mandate
+10 people
+15 investments
+5 public holdings
+10 regulatory record
+20 independent sources (4 sources)
Active deployment
no components; scored 0
Exists confidence
+50 regulatory identifier (CIK, CRD or EIN)
+30 independent sources (4 sources)
+30 analyst-verified
Research priority
+8 capital scale (largest of 13F, RAUM, AUM, foundation assets) ($49,601,478)
+15 single family or family investment company
+15 direct investments on record
+5 no decision-maker yet (research would add one)
+2 no website known (research would find one)
+0 rank (26)
Mandate confidence
+70 mandate supported by observed investments
+20 stated mandate on the record
Identity confidence
+90 classification (FAMILY_INVESTMENT_COMPANY (Steven A. Cohen's personal holding company at the Point72 address, of which he is the sole member.))
Real estate propensity
no components; scored 0
Co investment propensity
+10 participant in syndicated rounds
Family identity confidence
+60 wealth origin or operating company on the record
+40 family named (Steven A. Cohen (married to Alexandra Garcia since 1992))
+20 family principal on staff
Private markets propensity
+60 private markets investments observed
Current activity confidence
+25 filed a 13F for a recent quarter (the entity operates; not deployment)
+25 a source-dated fact within 12 months (5 days)
External manager propensity
no components; scored 0
Direct investment propensity
+70 observed direct investments (9 on the record)
Independent sponsor propensity
no components; scored 0
| Fact | Value | Effective | Source | Class |
|---|---|---|---|---|
| Aum stated | 13F reportable value $49.96M at 2026-06-30 (5 positions; public securities only) “Form 13F Information Table Value Total: 49,960,187” | Jun 30, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Co invest behavior | Invests alongside the Point72 Asset Management hedge fund in the same issuers (joint 13G filings) “This statement is filed by: (i) Point72 Asset Management, L.P. (“ Point72 Asset Management ”) with respect to shares of common stock, par value $0.001 per share (“ Common Stock ”), of the Issuer held ” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Control preference | Minority; positions typically below 5% at listing “Percent of class represented by amount in Row (9) 4.8% (see Item 4)” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Description | Under common control with Point72 Asset Management, CPV Partners (Cohen Private Ventures) and Point72 Private Investments, each of which files its own 13F “The Reporting Manager, 72 Investment Holdings, LLC, is under common control with Point72 Asset Management, L.P. (Form 13F File Number 028-16256), CPV Partners, LLC (Form 13F File Number 028-19347), an” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Edgar entity type | other | Sep 12, 2026 | SEC EDGAR entity submissions record (filer profile: forms filed, SIC, entity type, website) sec.gov | Fact |
| Edgar forms | 13F-HR,13F-NT,3,4,N-PX | Sep 12, 2026 | SEC EDGAR entity submissions record (filer profile: forms filed, SIC, entity type, website) sec.gov | Fact |
| Family served | Steven A. Cohen (married to Alexandra Garcia since 1992) “Steven A. Cohen (born June 11, 1956) is an American hedge fund manager and owner of the New York Mets of Major League Baseball (MLB).” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.org | Fact |
| Family wealth estimate | Forbes 2024 estimate $21.3B “In 2024, Forbes estimated Cohen's net worth at $21.3 billion, ranking him the 30th richest person in the United States.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.org | Fact |
| Filing address | 72 CUMMINGS POINT ROAD, Stamford, CT, 06902 | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Filing address | 72 CUMMINGS POINT ROAD, Stamford, CT, 06902 | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Filing address | 72 CUMMINGS POINT ROAD, Stamford, CT, 06902 | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Filing address | 72 Cummings Point Road, Stamford, CT, 06902 | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Filing address | 72 Cummings Point Road, Stamford, CT, 06902 | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Filing address | 72 Cummings Point Road, Stamford, CT, 06902 | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F filer | Y | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F filer | Y | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F filer | Y | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F filer | Y | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F filer | Y | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F filer | Y | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F admission signal | non_adviser_filer | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Other managers on 13F | 0 | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Other managers on 13F | 0 | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Other managers on 13F | 0 | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Other managers on 13F | 0 | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Other managers on 13F | 0 | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Other managers on 13F | 0 | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Latest 13F quarter | 2026-03-31 | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Latest 13F quarter | 2025-12-31 | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Latest 13F quarter | 2025-09-30 | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Latest 13F quarter | 2025-06-30 | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Latest 13F quarter | 2025-03-31 | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Latest 13F quarter | 2024-12-31 | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F positions | 5 | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F positions | 5 | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F positions | 5 | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F positions | 6 | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F positions | 6 | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F positions | 7 | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F table value | $49.6M | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F table value | $50.6M | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F table value | $67.9M | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F table value | $38.3M | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F table value | $35.6M | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| 13F table value | $49.1M | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Headquarters | 72 Cummings Point Road, Stamford, CT 06902 (Point72 campus) “72 Investment Holdings, and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Headquarters | Stamford, CT | Mar 31, 2026 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Headquarters | Stamford, CT | Dec 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Headquarters | Stamford, CT | Sep 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Headquarters | Stamford, CT | Jun 30, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Headquarters | Stamford, CT | Mar 31, 2025 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Headquarters | Stamford, CT | Dec 31, 2024 | SEC Form 13F data sets (quarterly holdings, all filers) sec.gov | Fact |
| Invests directly | Yes; pre-IPO and crossover biotech stakes through Point72 Biotech Private Investments “Consist of shares of Series D-1 Preferred Stock held directly by Point72 Biotech Private Investments, LLC (Point72 Biotech).” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Delaware LLC whose sole member is Steven A. Cohen; sole member of Differentiated Ventures Investments, LLC, managing member of Point72 Biotech Private Investments, LLC “(v) 72 Investment Holdings, LLC (“ 72 Investment Holdings ”), the sole member of Differentiated Ventures, with respect to the shares of Common Stock held by Point72 Biotech, and (vi) Steven A. Cohen (” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Differentiated Ventures Investments, LLC (managing member of Point72 Biotech Private Investments, LLC) “(iv) Differentiated Ventures Investments, LLC (“ Differentiated Ventures ”), the managing member of Point72 Biotech, with respect to the shares of Common Stock held by Point72 Biotech” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Legal entity | Point72 Biotech Private Investments, LLC (direct holding vehicle for private biotech stakes) “(iii) Point72 Biotech Private Investments, LLC (“ Point72 Biotech ”) with respect to shares of Common Stock of which it is the holder” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Office type (stated) | family_investment_company “Steven A. Cohen (SC), the sole member of 72 IH, deemed to have sole voting and investment control over such interest held by 72 IH.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Fact |
| Operating model inhouse | Administered from Point72's Stamford platform; filings signed by Point72 authorized signatories “72 Investment Holdings, LLC by: /s/Vincent Tortorella, Authorized Signatory” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Public stake filed (13D, 13G, Section 16) | Prometheus Biosciences, Inc. | Mar 11, 2021 | SEC EDGAR entity submissions record (filer profile: forms filed, SIC, entity type, website) sec.gov | Fact |
| Sectors | Biotechnology (immunology, gene editing, neuroscience, ophthalmology, RNA editing, oncology) “Differentiated Ventures is the managing member of Point72 Biotech and may be deemed to share beneficial ownership over the shares of Common Stock held by Point72 Biotech.” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Stage preference | Late-stage private (crossover) rounds ahead of IPOs or reverse mergers “effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series D-1 Preferred Stock will automatically convert at the ratio of ten-for-one ” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) sec.gov | Inference |
| Source of wealth | Hedge fund management: S.A.C. Capital Advisors (1992 to 2016) and Point72 Asset Management “In 2014, Cohen founded Point72 Asset Management as a family office .” | Sep 13, 2026 | DFX analyst research (General-assisted, every claim URL-cited) en.wikipedia.org | Fact |
| Website search | not_found | Sep 16, 2026 | DFX model output (classification rules, scores, mandates, matches) no URL | Inference |
| Website search | not_found | Sep 12, 2026 | DFX model output (classification rules, scores, mandates, matches) no URL | Inference |